65,437 trials
Peripheral Nerve Blocks
Primary: Time Needed to Correctly Identify the Neural Structure(s) and Induce the Peripheral Nerve Block — 2.606944444; 2.179761905 Minutes
Mood
Primary: BOLD fMRI (Neural Activation Patterns/Brain Function) Among Participants Who Completed Both Active and Sham Stimulation Visits
Type 2 Diabetes Mellitus · Vascular Disease
Primary: Change in Coronary Flow Reserve From Baseline to 6 Months — 0.33; -0.10; 0.02 ratio
Corneal Ulcer · Eye Infections, Fungal
Primary: Incidence of Perforation or Therapeutic Penetrating Keratoplasty — 0.0095562; 0.011204 New perforations or TPK/person-days — p=0.29
Diabetes Mellitus, Type 2
Primary: HbA1c Level Change Scores From Baseline to 16 Weeks — -0.60; -2.30; -2.33; -2.15 percent
Attention Deficit Hyperactivity Disorder (ADHD)
Primary: Change From Baseline in the Adult Attention-deficit/Hyperactivity Disorder Rating Scale-4 (ADHD-RS) With Prompts Total Score at Visit 6 (Week 4) — 40.5; 39.8; 39.9…
Healthy · Dyspnea
Primary: Subject Rating of Breathing Discomfort (Dyspnea) — 20; 20; 16; 17 units on a scale — p=0.99
Diabetic Foot Infection
Primary: Number of Participants With Clinical Response — 56; 54 Participants
Cervical Preparation
Primary: Length of Procedure — 14; 13.5 minutes
Postoperative Pain
Primary: Scores on Questionnaires — 95; 101 points — p=0.86
Marijuana Dependence
Primary: Urine Drug Screen — 0; 0 Participants
Head and Neck Cancer
Primary: Time Until the Maximum Oral Mucositis Measured From the Start of Radiation Treatment. — 34; 29 Days — p=0.9906
Prostate Cancer
Primary: Number of Participants With Androgen Receptor (AR) Related Mutations — 1 Participants
Cardiovascular Disease · Inflammation
Primary: Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment — 1.4; 1.3; 1.4; 1.5 pg/mL
Insulin Resistance · Type 2 Diabetes Mellitus · Obesity
Primary: Insulin Sensitivity Quantified by Matsuda Index — 5.0; 9.4; 7.2; 7.3 units on a scale — p=0.164